|Articles|June 28, 2016
DrugDev Launches CRO Program with INC Research
DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research.
Advertisement
DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research. Sponsors will be offered use of DrugDevs Golden Number, used to match and master data from disparate sources, and the new DrugDev patient engagment solution, which enables sites to send information, documents and notifications to patients via SMS.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Unlocking Unstructured Health Data: Scaling eSource-Enabled Clinical Trials
2
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
5